Facebook Instagram X-twitter Linkedin Youtube Spotify Apple
Santhera to Discontinue Phase 3 SIDEROS Study and Development of Puldysa(R) in Duchenne Muscular Dystrophy (DMD) and Focus on Vamorolone
October 6, 2020
Italfarmaco Shares a New Issue of Community Newsletter
October 21, 2020

Fall Update on Sarepta Community Programs

October 9, 2020

Sarepta Therapeutics shares a fall update on its community programs and highlights their involvement in World Duchenne Awareness Day efforts across the globe, including Jett Foundation’s week of events. Read the full update here.